Literature DB >> 28498445

Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.

Yang Zhou1, Dongdong Chen1, Yan Qi1, Ruixue Liu1, Shugang Li2, Hong Zou1, Jiaojiao Lan1, Xinxin Ju1, Jinfang Jiang1, Weihua Liang1, Yaoyuan Shen3, Lijuan Pang1, Feng Li4.   

Abstract

Synovial sarcoma (SS) is an aggressive soft tissue tumor, with uncertain histological and cellular origin. SYT-SSX is considered to be responsible for sarcoma initiation and progression. The histogenesis and pathogenesis of this tumor are poorly understood, and prognosis of patients of SS is unsatisfactory. Recent studies have shown an association of cancer stem cells with the initiation and development of tumors. We explored immunohistochemical expression level of stem cell associated markers to determine the possible histogenesis and pathogenesis of SS. Fusion gene SYT-SSX was tested to assess diagnostic value and the molecular pathological features. We obtained the clinicopathological data of 20 SS patients, immunohistochemical staining were used to evaluate stem cell-associated markers included CD133, CD29, CD44, nestin, and ALDH1. Fusion gene SYT-SSX was tested by reverse transcriptase-polymerase chain reaction (RT-PCR). Twenty SS cases were observed and the positive immuno-expression results showed CD133 (17/20), CD29 (11/20), CD44 (11/20), nestin (6/20), and ALDH1 (5/20). Fusion gene SYT-SSX was successfully detected by RT-PCR from 18 available samples. The expression of stem cell-associated markers (CD133, CD29, CD44, Nestin, and ALDH1) and clinical data (age, gender, sites, tumor size, histological type, tumor stage, and distant metastases) did not show statistically significant relationship (P>0.05), whereas, statistically significance between ALDH1 and metastases was observed (P<0.01). The ALDH1 positive synovial sarcoma (ALDH1+ SS) cases had significantly poor prognosis compared to ALDH1 negative synovial sarcoma (ALDH1- SS) cases (P<0.05). Immunohistochemical results indicated different expression levels of the five cancer stem cell markers in SS suggesting that SS may arise from cancer stem cells. Fusion gene SYT-SSX may play a critical role in the molecular pathological of SS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498445     DOI: 10.3892/or.2017.5617

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Detection of Disease-specific Fusion Genes of Soft Tissue Tumors Using Formalin-fixed Paraffin-embedded Tissues; Its Diagnostic Usefulness and Factors Affecting the Detection Rates.

Authors:  Takahiro Matsushige; Satoshi Kuwamoto; Michiko Matsushita; Lusi Oka Wardhani; Yasushi Horie; Kazuhiko Hayashi; Yukisato Kitamura
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

2.  Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.

Authors:  Livnat Jerby-Arnon; Cyril Neftel; Marni E Shore; Hannah R Weisman; Nathan D Mathewson; Matthew J McBride; Brian Haas; Benjamin Izar; Angela Volorio; Gaylor Boulay; Luisa Cironi; Alyssa R Richman; Liliane C Broye; Joseph M Gurski; Christina C Luo; Ravindra Mylvaganam; Lan Nguyen; Shaolin Mei; Johannes C Melms; Christophe Georgescu; Ofir Cohen; Jorge E Buendia-Buendia; Asa Segerstolpe; Malika Sud; Michael S Cuoco; Danny Labes; Simon Gritsch; Daniel R Zollinger; Nicole Ortogero; Joseph M Beechem; G Petur Nielsen; Ivan Chebib; Tu Nguyen-Ngoc; Michael Montemurro; Gregory M Cote; Edwin Choy; Igor Letovanec; Stéphane Cherix; Nikhil Wagle; Peter K Sorger; Alex B Haynes; John T Mullen; Ivan Stamenkovic; Miguel N Rivera; Cigall Kadoch; Kai W Wucherpfennig; Orit Rozenblatt-Rosen; Mario L Suvà; Nicolò Riggi; Aviv Regev
Journal:  Nat Med       Date:  2021-01-25       Impact factor: 87.241

3.  CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.

Authors:  Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Takuya Kato; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L Choyke; Hisataka Kobayashi
Journal:  Oncoimmunology       Date:  2022-01-04       Impact factor: 8.110

4.  SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling.

Authors:  Yan Qi; Shuang-Shuang Dong; Yong-Lai He; Zi-Han Liu; Ya-Lan Huang; Ning Wang; Zhen Zhang; Zhong Li; Mei Er Tu He Ta Mi Shi; Xiao Feng; Qing Yao; Hong Zou; Jian-Ming Hu; Li-Juan Pang; Feng Li
Journal:  BMC Cancer       Date:  2022-02-12       Impact factor: 4.430

Review 5.  CD44 In Sarcomas: A Comprehensive Review and Future Perspectives.

Authors:  Enrique Fernández-Tabanera; Raquel M Melero-Fernández de Mera; Javier Alonso
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 6.  Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition.

Authors:  Yongxu Chen; Changjun Wang; Wei Tan
Journal:  Onco Targets Ther       Date:  2018-07-04       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.